Donoghue Forlines’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,334
Closed -$1.23M 142
2026
Q1
$1.23M Sell
1,334
-1,499
-53% -$1.52M 0.34% 101
2025
Q4
$3.04M Buy
+2,833
New +$2.71M 0.94% 13
2025
Q2
Sell
-2,737
Closed -$2.26M 124
2025
Q1
$2.26M Buy
+2,737
New +$2.28M 0.72% 42
2024
Q1
Sell
-2,254
Closed -$1.31M 249
2023
Q4
$1.31M Sell
2,254
-139
-6% -$81.1K 0.41% 71
2023
Q3
$1.29M Sell
2,393
-420
-15% -$216K 0.46% 57
2023
Q2
$1.32M Sell
2,813
-2,503
-47% -$1.05M 0.41% 53
2023
Q1
$1.83M Buy
5,316
+89
+2% +$30K 0.66% 23
2022
Q4
$1.91M Buy
5,227
+791
+18% +$280K 0.68% 25
2022
Q3
$1.43M Sell
4,436
-4,638
-51% -$1.47M 0.52% 17
2022
Q2
$2.94M Sell
9,074
-2,862
-24% -$859K 0.77% 17
2022
Q1
$3.42M Buy
11,936
+366
+3% +$94.2K 0.74% 19
2021
Q4
$3.2M Sell
11,570
-84
-0.7% -$21.3K 0.54% 26
2021
Q3
$2.69M Buy
+11,654
New +$2.88M 0.52% 36
2021
Q2
Sell
-8,523
Closed -$1.59M 224
2021
Q1
$1.59M Buy
8,523
+1,616
+23% +$316K 0.31% 80
2020
Q4
$1.17M Buy
+6,907
New +$1.03M 0.23% 112
2018
Q4
Sell
-153,186
Closed -$16.4M 95
2018
Q3
$16.4M Sell
153,186
-59,306
-28% -$5.93M 1.28% 11
2018
Q2
$18.1M Sell
212,492
-12,113
-5% -$995K 1.5% 11
2018
Q1
$17.4M Buy
+224,605
New +$18.1M 1.51% 20
2017
Q4
Sell
-194,866
Closed -$16.7M 136
2017
Q3
$16.7M Sell
194,866
-2,221
-1% -$182K 1.76% 31
2017
Q2
$16.2M Buy
+197,087
New +$16.1M 1.84% 21

Other funds holding LLY

Donoghue Forlines's LLY Position: Q2 2026 in Review

Donoghue Forlines sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 1,334 shares — an estimated $1.23M sold.

Donoghue Forlines first reported a position in LLY in Q2 2017 and held it in 20 quarters. The position peaked at $18.1M in Q2 2018. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Donoghue Forlines reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Donoghue Forlines sold 1,334 Eli Lilly shares in Q2 2026, an estimated $1.23M.
  • Donoghue Forlines first reported a position in Eli Lilly in Q2 2017 and held it in 20 quarters.
  • Donoghue Forlines's Eli Lilly position peaked at $18.1M in Q2 2018.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Donoghue Forlines's 13F filing for Q2 2026, filed 7 Aug 2026.